Elias Sayour, MD, PhD - Research

Research at a glance

Top areas of exploration

Glioblastoma , 12 publications
Immunotherapy , 11 publications
Brain Neoplasms , 10 publications
Tumor Microenvironment , 9 publications

Research activity

54 publications

2,084 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells鈥�

Investigators: Elias Sayour, Jennifer F King
Status: Accepting Candidates
Ages: 1 Year - 21 Years
Sexes: All

My publications

54 publications

2016

FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.

Histopathology

鈥�

2016

Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.

Cancer immunology, immunotherapy : CII

鈥�

2015

A novel ELANE gene mutation in a patient with severe congenital neutropenia and intermittent thrombocytopenia.

Pediatric blood & cancer

鈥�

2015

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.

Journal for immunotherapy of cancer

鈥�

2015

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.

Cancer immunology, immunotherapy : CII

鈥�

BOB体育

Research at a glance

Top areas of exploration

Research activity

Focus

Active clinical trials

My publications

Filter publications

FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers.

Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.

A novel ELANE gene mutation in a patient with severe congenital neutropenia and intermittent thrombocytopenia.

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.